Isomorphic Labs, a Google DeepMind spinoff, is advancing AI-driven drug discovery by developing new computational systems. Their Isomorphic Drug Design Engine (IsoDDE) builds upon AlphaFold's protein structure prediction capabilities to model complex biomolecular interactions. IsoDDE aims to identify novel drug targets, including previously unobserved protein pockets, and predict binding affinities, addressing limitations of earlier models. AI
IMPACT This AI system could accelerate the identification of novel drug targets and improve the efficiency of drug development pipelines.
RANK_REASON The article describes a technical report detailing a new AI system for drug discovery, building on prior research. [lever_c_demoted from research: ic=1 ai=1.0]
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →
